Public Assessment Reports for medicines

In accordance with this Directive, the MHRA makes the assessment reports available for all new licences granted after 30 October 2005, albeit with commercially or personally confidential information removed.

The compilation and editing of the original assessment reports into the Public Assessment Reports are performed by experienced medical writers. The draft copies of the Public Assessment Reports are then checked by medical, pharmaceutical, and, if necessary, preclinical and statistical assessors. The assessment reports are amended to incorporate any assessors’ comments. Before being made available to the public, all Public Assessment Reports are sent to the Marketing Authorisation holder (or a designated person of their choice) for comment.

Latest Public Assessment Reports

• 09 Feb 2010 |  Paracetamol 500 mg Capsules - PL 31308/0004-6 (910Kb)
  

• 05 Feb 2010 |  Donepezil Hydrochloride 5 mg and 10 mg Orodispersible Tablets - PL 00289/1135-6; UK/H/1515/001-2/DC (2177Kb)
  

• 05 Feb 2010 |  Losartan Potassium/Hydrochlorothiazide 50 mg/12.5 mg and 100 mg/25 mg Tablets - PL 20092/0048-9 (1075Kb)
  

• 04 Feb 2010 |  Ceftazidime 3 g Powder for Solution for Injection/Infusion - PL 22805/0027; UK/H/1486/001/DC (839Kb)
  

• 04 Feb 2010 |  Anadin LiquiFast 200 mg and 400 mg Effervescent Tablets (Ibuprofen) - PL 00165/0372-3; UK/H/3031/001-002/DC (647Kb)
  

• 03 Feb 2010 |  Cytarabine 100 mg/ml Solution for Injection or Infusion - UK/H/1641/001/DC; PL 20075/0121 (401Kb)
  

• 03 Feb 2010 |  Ondansetron 2 mg/ml Solution for Injection - UK/H/1250/001/DC; PL 20075/0082 (507Kb)
  

• 02 Feb 2010 |  Glycopyrronium Bromide 200 micrograms/ml injection - PL 20910/0006 (762Kb)
  

• 02 Feb 2010 |  Mictonorm/Propinorm XL 45mg Modified Release Capsules (propiverine hydrochloride) - PL 15072/0010-11 (2083Kb)
  

• 01 Feb 2010 |  Simvastatin 10 mg, 20 mg, 40 mg and 80 mg film-coated tablets - PL 11311/0398-401 (1493Kb)